
Dr. Moopen’s Family Invests Rs 460 Cr, Raises Stake in Aster DM Healthcare by 4%
Key Points of Dr. Moopen’s Family Stake Raises in Aster DM Healthcare: Details of Dr. Moopen’s Family Stake Raises in…
Key Points of Dr. Moopen’s Family Stake Raises in Aster DM Healthcare: Details of Dr. Moopen’s Family Stake Raises in…
Key Points of Sun Pharma Acquire Stake in Vivaldis Health and Foods: Details of Sun Pharma Acquire Stake in Vivaldis…
Key Points of Eric Acquisition of Dr. Reddy’s Dermatology Brands: Details of Eric Acquisition of Dr. Reddy’s Dermatology Brands: Indian…
The US health authorities has given Glenmark Pharmaceuticals permission to market a generic antibiotic medicine, the company announced on Tuesday….
Pfizer Strikes $43 Billion Deal with Seagen to Expand Cancer Treatments Portfolio Pfizer Inc, the renowned drugmaker, has announced a…
Zydus Lifesciences Gets USFDA Approval to Market Olanzapine Orally Disintegrating Tablets Zydus Lifesciences, a leading global pharmaceutical company, has received…
Marksans Pharma Secures USFDA Approval for Famotidine Tablets Marksans Pharma announced on Friday that the United States Food and Drug…
Ajanta Pharma Approves Buyback of Shares Worth ₹315 Crore Pharmaceutical company Ajanta Pharma’s board has approved a share buyback proposal…
Key Points of Share Buyback: Details of Share Buyback: Ajanta Pharma Announces Third Share Buyback in Three Years On Friday,…
Key Points of Nod: Details of Nod: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA)…